The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Expression of Concern: Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease
Abstract
Cerebral deposition of amyloid β‐peptide (Aβ) in the brain is an invariant feature of Alzheimer's disease (AD). A consistent protective effect of wine consumption on AD has been documented by epidemiological studies. In the present study, we used fluorescence spectroscopy with thioflavin T and electron microscopy to examine the effects of wine‐related polyphenols (myricetin, morin, quercetin, kaempferol (+)‐catechin and (–)‐epicatechin) on the formation, extension, and destabilization of β‐amyloid fibrils (fAβ) at pH 7.5 at 37°C in vitro. All examined polyphenols dose‐dependently inhibited formation of fAβ from fresh Aβ(1–40) and Aβ(1–42), as well as their extension. Moreover, these polyphenols dose‐dependently destabilized preformed fAβs. The overall activity of the molecules examined was in the order of: myricetin = morin = quercetin > kaempferol > (+)‐catechin = (–)‐epicatechin. The effective concentrations (EC 50) of myricetin, morin and quercetin for the formation, extension and destabilization of fAβs were in the order of 0.1–1 µ m. In cell culture experiments, myricetin‐treated fAβ were suggested to be less toxic than intact fAβ, as demonstrated by 3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyltetrazolium bromide assay. Although the mechanisms by which these polyphenols inhibit fAβ formation from Aβ, and destabilize pre‐formed fAβ in vitro are still unclear, polyphenols could be a key molecule for the development of preventives and therapeutics for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices
Hertog, M. G. L., Hollman, P. C. H., & van de Putte, B. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00032a015 · Cited by 895
Resveratrol: A molecule whose time has come? And gone?
Soleas, G. J., Diamandis, E. P., & Goldberg, D. M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00155-5 · Cited by 849
Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., & Mandel, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00490.x · Cited by 567
Kinetic theory of fibrillogenesis of amyloid β-protein
Lomakin, A., Teplow, D. B., Kirschner, D. A., & Benedek, G. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7942 · Cited by 529
Suganuma, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.10.1771 · Cited by 525
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
Orgogozo, J. M., Dartigues, J. F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., & Breteler, M. M. B. (1997) · PubMed · Cited by 523
Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet Conformation
Soto, C., Kindy, M. S., Baumann, M., & Frangione, B. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1413 · Cited by 431
Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363
Choi, Y.-T., Jung, C.-H., Lee, S.-R., Bae, J.-H., Baek, W.-K., Suh, M.-H., Park, J., Park, C.-W., & Suh, S.-I. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01438-2 · Cited by 342
Inhibition of Alzheimer β-Fibrillogenesis by Melatonin
Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N. K., Zagorski, M., Frangione, B., & Ghiso, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7185 · Cited by 337
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703626 · Cited by 302
Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
Tomiyama, T., Shoji, A., Kataoka, K.-I., Suwa, Y., Asano, S., Kaneko, H., & Endo, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6839 · Cited by 295
[20] Kinetic analysis of amyloid fibril formation
(1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09022-9 · Cited by 287
Amount and type of alcohol and risk of dementia: The Copenhagen City Heart Study
Truelsen, T., Thudium, D., & Grønbæk, M. (2002) · Neurology · doi:10.1212/01.wnl.0000031421.50369.e7 · Cited by 280
New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., & Takashima, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010706200 · Cited by 244 · cited 3×
“Ten lM fAb(1–40) were incubated with 0 or 0.2% DMSO, or 10 lM Myr + 0.2% DMSO at pH 7.5 at 37 C. ThT fluorescence was regularly monitored as described in Yoshiike et al. (2001).”
BackgroundMethodInfluentialSelf-citationFirst-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.
Naiki, H., & Nakakuki, K. (1996) · PubMed · Cited by 244
Self-citationAnti‐amyloidogenic activity of tetracyclines: studies in vitro
Forloni, G., Colombo, L., Girola, L., Tagliavini, F., & Salmona, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02380-2 · Cited by 242
Method To Assay the Concentrations of Phenolic Constituents of Biological Interest in Wines
Goldberg, D. M., Tsang, E., Karumanchiri, A., Diamandis, E. P., Soleas, G., & Ng, E. (1996) · Analytical Chemistry · doi:10.1021/ac951083i · Cited by 240
Virgili, M., & Contestabile, A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00820-x · Cited by 233
Goodman, Y., Steiner, M. R., Steiner, S. M., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91586-5 · Cited by 202
Interaction between Aβ(1−42) and Aβ(1−40) in Alzheimer's β-Amyloid Fibril Formation in Vitro
Hasegawa, K., Yamaguchi, I., Omata, S., Gejyo, F., & Naiki, H. (1999) · Biochemistry · doi:10.1021/bi991161m · Cited by 198
Self-citationShutenko, Z., Henry, Y., Pinard, E., Seylaz, J., Potier, P., Berthet, F., Girard, P., & Sercombe, R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00296-2 · Cited by 161
Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro
Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K., Mori, H., & Endo, N. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2428 · Cited by 158
Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone
Celotti, E., Ferrarini, R., Zironi, R., & Conte, L. S. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(95)00962-0 · Cited by 145
Inanami, O., Watanabe, Y., Syuto, B., Nakano, M., Tsuji, M., & Kuwabara, M. (1998) · Free Radical Research · doi:10.1080/10715769800300401 · Cited by 135
Linert, W., Bridge, M. H., Huber, M., Bjugstad, K. B., Grossman, S. H., & Arendash, G. W. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00029-0 · Cited by 123
Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Yoshiike, Y., Takashima, A., Yamada, M., & Naiki, H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00904.x · Cited by 122
Self-citationNaiki, H., Gejyo, F., & Nakakuki, K. (1997) · Biochemistry · doi:10.1021/bi9624705 · Cited by 120
Self-citationNaiki, H., Hasegawa, K., Yamaguchi, I., Nakamura, H., Gejyo, F., & Nakakuki, K. (1998) · Biochemistry · doi:10.1021/bi980550y · Cited by 119
Self-citationHasegawa, K., Ono, K., Yamada, M., & Naiki, H. (2002) · Biochemistry · doi:10.1021/bi020369w · Cited by 117
Self-citationNicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro
Ono, K., Hasegawa, K., Yamada, M., & Naiki, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01417-8 · Cited by 116
Self-citationSato, M., Suzuki, Y., Okuda, T., & Yokotsuka, K. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.1800 · Cited by 115
Abe, K., & Saitō, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00055-8 · Cited by 81
Nicotine and amyloid formation
Zeng, H., Zhang, Y., Peng, L., Shao, H., Menon, N. K., Yang, J., Salomon, A. R., Freidland, R. P., & Zagorski, M. G. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01111-2 · Cited by 81
The role of alcohol in the anti low density lipoprotein oxidation activity of red wine
van Golde, P. M., Sloots, L., Vermeulen, W. P., Wielders, J. P. M., Hart, H. C., Bouma, B. N., & van de Wiel, A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00206-3 · Cited by 67
Dorozynski, A. (1997) · BMJ · doi:10.1136/bmj.314.7086.993j · Cited by 31
Wine Consumption in the Elderly
Letenneur, L., Dartigues, J., & Orgogozo, J. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00028 · Cited by 25
Cited by
A Review on the Dietary Flavonoid Kaempferol
M. Calderon-Montano, J., Burgos-Moron, E., Perez-Guerrero, C., & Lopez-Lazaro, M. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711795305335 · Cited by 1,383
A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding
Perron, N. R., & Brumaghim, J. L. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9043-x · Cited by 1,370
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Self-citationPorat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Metadata
- Authors
- Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2003-09-12
- Volume
- 87
- Issue
- 1
- Pages
- 172-181
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1487727801
- Cited by
- 681
- References
- 44
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.